CN Stock MarketDetailed Quotes
301367 BMC Medical
- 64.35
- -1.17-1.79%
Market Closed Dec 25 15:00 CST
5.77BMarket Cap37.94P/E (TTM)
66.18High63.86Low4.58KlotVolume65.56Open65.52Pre Close29.63MTurnover0.81%Turnover Ratio19.39P/E (Static)89.60MShares95.7552wk High2.06P/B3.64BFloat Cap50.3652wk Low78.62Limit Up56.52MShs Float236.34Historical High52.42Limit Down3.54%Amplitude50.36Historical Low0.71Dividend TTM64.66Avg Price3.00KlotAsk1.11%Div YieldTTM100Lot Size1.44KlotBid
BMC Medical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -36.31%602.08M | -48.79%382.17M | -60.02%192.09M | -20.70%1.12B | -6.81%945.3M | 32.58%746.29M | 131.85%480.44M | 113.64%1.42B | 123.64%1.01B | 106.31%562.9M |
| Operating revenue | -36.31%602.08M | -48.79%382.17M | -60.02%192.09M | -20.70%1.12B | -6.81%945.3M | 32.58%746.29M | 131.85%480.44M | 113.64%1.42B | 123.64%1.01B | 106.31%562.9M |
| Other operating revenue | ---- | -39.23%667.27K | ---- | 14.87%3.01M | ---- | 22.43%1.1M | ---- | 84.66%2.62M | ---- | 344.78%896.89K |
| Total operating cost | -28.75%507.04M | -39.37%317.01M | -51.79%149M | -15.03%870.69M | -2.12%711.63M | 29.99%522.86M | 104.41%309.05M | 94.67%1.02B | 115.94%727.03M | 97.40%402.22M |
| Operating cost | -42.13%293.84M | -54.12%184.57M | -63.59%92.69M | -26.82%604.52M | -16.67%507.73M | 21.80%402.26M | 112.62%254.54M | 119.70%826.09M | 155.44%609.29M | 135.54%330.26M |
| Operating tax surcharges | 23.67%6.8M | -60.40%1.84M | -82.46%612.12K | -25.60%6.43M | -1.64%5.5M | 73.95%4.66M | 361.29%3.49M | 114.45%8.64M | 56.57%5.59M | 0.72%2.68M |
| Operating expense | 1.65%77.97M | 3.64%48.41M | 2.96%20.72M | 24.55%106.61M | 34.72%76.7M | 36.32%46.71M | 45.57%20.13M | 22.06%85.59M | 21.78%56.93M | 18.05%34.27M |
| Administration expense | 33.72%43.29M | 57.38%30.18M | 33.17%11.45M | -16.35%40.28M | 30.98%32.37M | 24.57%19.18M | 72.34%8.59M | 79.06%48.15M | 38.89%24.72M | 27.58%15.4M |
| Financial expense | -38.93%-5.5M | -12.77%-6.15M | -157.90%-1.6M | 75.19%-4.11M | 68.59%-3.96M | -13.70%-5.46M | 233.95%2.76M | -1,631.63%-16.58M | -1,953.29%-12.61M | -763.44%-4.8M |
| -Interest expense (Financial expense) | 122.35%2.32M | -17.92%587.36K | -18.19%292.89K | 192.57%1.36M | 195.13%1.04M | 527.67%715.63K | 759.50%358.02K | 135.82%463.67K | 136.48%353.6K | 8.98%114.01K |
| -Interest Income (Financial expense) | -91.46%-7.13M | -87.56%-4.72M | -10.25%-1.48M | -16.09%-6.18M | -163.74%-3.73M | -179.80%-2.52M | -451.24%-1.34M | -72.14%-5.33M | 43.94%-1.41M | 51.65%-898.98K |
| Research and development | -2.84%90.64M | 4.75%58.15M | 28.63%25.13M | 60.54%116.98M | 116.44%93.29M | 127.34%55.51M | 76.35%19.54M | 50.92%72.86M | 40.64%43.1M | 20.01%24.42M |
| Credit Impairment Loss | 33.83%-1.82M | 134.08%769.24K | 76.98%-475.48K | 39.31%-2.29M | 17.01%-2.75M | -176.10%-2.26M | -132.73%-2.07M | -1,477.15%-3.77M | -1,441.39%-3.31M | -280.71%-817.61K |
| Asset Impairment Loss | ---876.46K | ---854.4K | ---- | ---10.23M | ---- | ---- | ---- | --0 | ---- | ---- |
| Other net revenue | -31.59%51.52M | -33.91%37.8M | 2.99%12.59M | 90.53%86.08M | 224.94%75.32M | 287.34%57.2M | 148.88%12.23M | 61.86%45.18M | 19.02%23.18M | 26.08%14.77M |
| Fair value change income | --1.95M | --118K | --118K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Invest income | -1.88%39.11M | -13.65%26.01M | -39.75%6.28M | 287.23%57.17M | 351.91%39.86M | 350.21%30.12M | 259.70%10.42M | 74.45%14.76M | 50.33%8.82M | 79.45%6.69M |
| -Including: Investment income associates | ---- | -7.21%-173.88K | -3.25%-246.11K | -111.55%-304.26K | -106.57%-172.99K | -109.75%-162.18K | -143.98%-238.35K | 13.88%2.63M | --2.63M | 29.36%1.66M |
| Asset deal income | -58.13%199.81K | -53.33%203.52K | -155.09%-37.86K | 2,206.59%477.21K | 2,206.59%477.21K | 3,380.57%436.11K | --68.73K | --20.69K | --20.69K | --12.53K |
| Other revenue | -65.67%12.95M | -60.02%11.56M | 76.31%6.71M | 19.86%40.95M | 113.77%37.73M | 225.39%28.9M | 31.07%3.81M | 73.54%34.17M | 27.68%17.65M | 8.33%8.88M |
| Operating profit | -52.57%146.57M | -63.31%102.96M | -69.68%55.67M | -22.48%337.81M | -0.51%308.99M | 59.96%280.63M | 201.32%183.62M | 165.72%435.79M | 127.70%310.58M | 117.12%175.44M |
| Add:Non operating Income | 200.04%173.95K | -72.41%15.9K | -77.62%12.9K | -85.00%107.43K | -91.11%57.97K | -91.16%57.64K | -72.69%57.64K | 718.40%716.11K | 2,269.00%651.8K | 61,982.49%651.8K |
| Less:Non operating expense | -43.26%1.82M | -88.52%348.31K | -97.79%54.21K | 174.42%3.88M | 471.84%3.21M | 455.12%3.03M | 1,742.59%2.46M | 522.00%1.42M | 901.13%561.51K | 170,826,156.25%546.64K |
| Total profit | -52.62%144.92M | -63.04%102.63M | -69.30%55.63M | -23.23%334.03M | -1.56%305.83M | 58.16%277.66M | 197.00%181.22M | 165.52%435.09M | 127.81%310.67M | 117.25%175.55M |
| Less:Income tax cost | -46.84%17.37M | -72.17%8.9M | -79.15%5.08M | -36.74%34.2M | -20.24%32.68M | 38.98%31.99M | 212.74%24.36M | 197.33%54.06M | 132.64%40.97M | 138.98%23.02M |
| Net profit | -53.31%127.55M | -61.85%93.72M | -67.77%50.55M | -21.31%299.83M | 1.28%273.15M | 61.06%245.66M | 194.70%156.87M | 161.55%381.03M | 127.10%269.7M | 114.31%152.53M |
| Net profit from continuing operation | -53.31%127.55M | -61.85%93.72M | -67.77%50.55M | -21.31%299.83M | 1.28%273.15M | 61.06%245.66M | 194.70%156.87M | 161.55%381.03M | 127.10%269.7M | 114.31%152.53M |
| Net income from discontinuing operating | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Less:Minority Profit | -9.38%2.43M | -35.00%1.35M | -54.90%640.12K | 237.57%2.49M | --2.68M | --2.08M | --1.42M | --738.11K | ---- | ---- |
| Net profit of parent company owners | -53.74%125.12M | -62.08%92.38M | -67.89%49.91M | -21.81%297.34M | 0.29%270.48M | 59.70%243.59M | 192.03%155.45M | 161.05%380.3M | 127.10%269.7M | 114.31%152.53M |
| Earning per share | ||||||||||
| Basic earning per share | -66.90%1.399 | -72.97%1.03 | -67.90%0.78 | -38.08%4.65 | -24.78%4.2262 | 19.81%3.81 | 118.92%2.43 | 147.04%7.51 | --5.6188 | 114.86%3.18 |
| Diluted earning per share | -66.90%1.399 | -72.97%1.03 | -67.90%0.78 | -38.08%4.65 | -24.78%4.2262 | 19.81%3.81 | 118.92%2.43 | 147.04%7.51 | --5.6188 | 114.86%3.18 |
| Other composite income | 157.10%15.37K | -9.3K | -13.05K | -4.26K | -26.92K | 0 | 0 | |||
| Other composite income of parent company owners | 157.10%15.37K | ---9.3K | ---13.05K | ---4.26K | ---26.92K | ---- | ---- | --0 | --0 | ---- |
| Total composite income | -53.30%127.56M | -61.85%93.72M | -67.78%50.54M | -21.31%299.83M | 1.27%273.13M | 61.06%245.66M | 194.70%156.87M | 161.55%381.03M | 127.10%269.7M | 114.31%152.53M |
| Total composite income of parent company owners | -53.73%125.14M | -62.08%92.37M | -67.90%49.9M | -21.81%297.34M | 0.28%270.45M | 59.70%243.59M | 192.03%155.45M | 161.05%380.3M | 127.10%269.7M | 114.31%152.53M |
| Total composite income of minority owners | -9.38%2.43M | -35.00%1.35M | -54.90%640.12K | 237.57%2.49M | --2.68M | --2.08M | --1.42M | --738.11K | ---- | ---- |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
